Effects of an intensive lifestyle intervention and the role of sleep in people living with HIV and prediabetes: a pilot and feasibility study.
Effects of an intensive lifestyle intervention and the role of sleep in people living with HIV and prediabetes: a pilot and feasibility study.
复制标题
强化生活方式干预的影响和睡眠在艾滋病毒感染者和前驱糖尿病患者中的作用:试点和可行性研究
DOI:
10.1186/s13104-021-05558-z
复制
发表时间:
2021-04-17
影响因子:
1.8
通讯作者:
Reutrakul S
中科院分区:
文献类型:
--
作者:
Nimitphong H;Sungkanuparph S;Areevut C;Saetung S;Jerawatana R;Hathaidechadusadee A;Somwang S;Tongchom W;Saibuathong N;Sakmanarit J;Pichitchaipitak O;Phuphuakrat A;Reutrakul S
Prediabetes is prevalent in people living with HIV (PLWH). Insufficient and irregular sleep are linked to abnormal glucose metabolism. This study aimed to investigate the differences in sleep characteristics between PLWH with and without prediabetes, determine the acceptability/feasibility and effects of a pilot six-month intensive lifestyle intervention (ILI) program on glucose metabolism in those with prediabetes, and determine how sleep modulates these effects. Thirty-nine PLWH (20 normoglycemia and 19 prediabetes) participated. There were no differences in sleep characteristics between individuals with normoglycemia and prediabetes. Next, thirteen individuals with prediabetes completed a six-month ILI program. The ILI program resulted in significant body weight reduction at 6 months (63.5 ± 13.9 to 61.9 ± 14.0 kg, p = 0.012), which was maintained at 12 months (p < 0.001). Waist circumferences were significantly decreased at 12 months (85.4 ± 11.7 to 82.9 ± 12.7 cm, p = 0.014). An increase in sleep variability was significantly associated with an increase in 2-h plasma glucose, independent of changes in BMI (b = 0.603), and physical activity (b = 0.774). This pilot study suggested that ILI in PLWH with prediabetes is feasible and effective in improving metabolic control, with its effects possibly modulated by sleep variability. These findings should be confirmed in a larger study to reduce diabetes risk in this population. Trail registration: ClinicalTrial.gov, NCT03545217 (date of registration: May 22, 2018)
登录
查看更多内容
影响因子:
158.5
作者:
Knowler, WC;Barrett-Connor, E;Nathan, DM
通讯作者:
Nathan, DM
DOI:
10.1038/nrendo.2011.151
发表时间:
2011-09-20
期刊:
Nature reviews. Endocrinology
影响因子:
--
作者:
通讯作者:
--
影响因子:
4.6
作者:
Huang X;Li H;Meyers K;Xia W;Meng Z;Li C;Bai J;He S;Cai W;Huang C;Liu S;Wang H;Ling X;Ma P;Tan D;Wang F;Ruan L;Zhao H;Wei H;Liu Y;Yu J;Lu H;Wang M;Zhang T;Chen H;Wu H
通讯作者:
Wu H
影响因子:
3.5
作者:
Duncan, A. D.;Peters, B. S.;Goff, L. M.
通讯作者:
Goff, L. M.
影响因子:
4.9
作者:
Kjeldsen, J. S.;Hjorth, M. F.;Sjodin, A.
通讯作者:
Sjodin, A.